Neochem Bio Solutions

| Annual Financials | 2024 | 2025 | TTM |
Revenue  | 62 | 86 | 0 |
| Expenses | 55 | 71 | 0 |
EBITDA  | 7 | 15 | 0 |
| Operating Profit % | 10 % | 16 % | 0 % |
| Depreciation | 1 | 1 | 0 |
| Interest | 3 | 4 | 0 |
Profit Before Tax  | 3 | 10 | 0 |
| Tax | 1 | 3 | 0 |
| Net Profit | 2 | 8 | 0 |
| EPS in ₹ | 1.90 | 6.64 | 0.00 |
Above figures are in Rs. Crores | Balance Sheet | 2024 | 2025 |
Total Assets  | 64 | 79 |
| Fixed Assets | 19 | 19 |
| Current Assets | 39 | 53 |
| Capital Work in Progress | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 45 | 60 |
Total Liabilities  | 64 | 79 |
| Current Liabilities | 33 | 44 |
| Non Current Liabilities | 19 | 15 |
Total Equity  | 12 | 20 |
| Reserve & Surplus | 5 | 13 |
| Share Capital | 7 | 7 |
Above figures are in Rs. Crores | Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | -0 |
| Investing Activities | -3 | -8 | -2 |
| Operating Activities | -1 | 2 | 3 |
| Financing Activities | 4 | 6 | -1 |
Above figures are in Rs. Crores | % Holding | Aug 2025 | Nov 2025 | Dec 2025 |
| Promoter | 91.12 % | 91.12 % | 66.70 % |
| FIIs | 0.00 % | 0.00 % | 1.99 % |
| DIIs | 0.00 % | 0.00 % | 13.19 % |
| Government | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 15.83 % |
| Others | 8.88 % | 8.88 % | 2.29 % |
| No of Share Holders | 14 | 14 | 14 |